FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccine | Sinovac | Healive

China suspends vax doses following minor's death

Tools
  • Email
  • Print
  • Comment
  • Contact Author
  • Reprint

China's Sinovac Biotech says that health officials in Beijing suspended the use of 83 doses of the inactivated hepatitis A vaccine Healive after a minor died two days after being vaccinated. Sinovac noted that out of the 19,850 doses distributed from the same lot of vaccines, no other adverse events had been recorded.

On November 29, regulators inspected Sinovac's manufacturing facility and reviewed its inspections and sales process without finding any irregularities, according to the company. Sinovac says it will continue to cooperate with the authorities and plans a follow-up report.

- check out the Sinovac release
- read RTTNews coverage

Related Article:
Sinovac to mass produce bird flu vaccine (2006)

More stories about Vaccine   Sinovac   Healive  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.